India's pharmaceutical exports rise 4.9% to $16.14 billion in H1FY27 as European shipments climb

Exam-focused facts from the 29 October 2026 current affairs briefing.

Key facts

India's pharmaceutical exports grew 4.90% year-on-year to $16.14 billion during the first half of 2026-27 (H1FY27), driven by non-US markets even as shipments to the US moderated, per the Pharmaceutical Export Promotion Council of India (Pharmexcil).
Exports to Europe rose 9.66% to $3.29 billion, accounting for over one-fifth of total pharmaceutical exports in H1FY27, with Germany, the Netherlands and France recording strong growth.
Shipments to ASEAN grew 21.54%, Latin America and the Caribbean grew 16.58%, and Africa grew 6.48% in H1FY27.
Drug formulations and biologicals remained the largest export category at 73.84% of total shipments, with its share growing 3.81% over the previous corresponding period.
Bulk drugs and drug intermediates grew 12.07%, while surgical exports increased 9.53% in H1FY27.